BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Martini DJ, Shabto JM, Goyal S, Liu Y, Olsen TA, Evans ST, Magod BL, Ravindranathan D, Brown JT, Yantorni L, Russler GA, Caulfield S, Goldman JM, Nazha B, Joshi SS, Kissick HT, Ogan KE, Harris WB, Kucuk O, Carthon BC, Master VA, Bilen MA. Body Composition as an Independent Predictive and Prognostic Biomarker in Advanced Urothelial Carcinoma Patients Treated with Immune Checkpoint Inhibitors. Oncologist 2021. [PMID: 34342095 DOI: 10.1002/onco.13922] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Engelmann SU, Pickl C, Haas M, Kaelble S, Hartmann V, Firsching M, Lehmann L, Gužvić M, van Rhijn BWG, Breyer J, Burger M, Mayr R. Body Composition of Patients Undergoing Radical Cystectomy for Bladder Cancer: Sarcopenia, Low Psoas Muscle Index, and Myosteatosis Are Independent Risk Factors for Mortality. Cancers 2023;15:1778. [DOI: 10.3390/cancers15061778] [Reference Citation Analysis]
2 Trinkner P, Günther S, Monsef I, Kerschbaum E, von Bergwelt-Baildon M, Cordas Dos Santos DM, Theurich S. Survival and immunotoxicities in association with sex-specific body composition patterns of cancer patients undergoing immune-checkpoint inhibitor therapy - A systematic review and meta-analysis. Eur J Cancer 2023;184:151-71. [PMID: 36931074 DOI: 10.1016/j.ejca.2023.01.030] [Reference Citation Analysis]
3 Pickl C, Engelmann S, Girtner F, Gužvić M, van Rhijn BWG, Hartmann V, Holbach S, Kälble S, Haas M, Rosenhammer B, Breyer J, Burger M, Mayr R. Body Composition as a Comorbidity-Independent Predictor of Survival following Nephroureterectomy for Urothelial Cancer of the Upper Urinary Tract. Cancers (Basel) 2023;15. [PMID: 36672398 DOI: 10.3390/cancers15020450] [Reference Citation Analysis]
4 Li J, Chen Z, Chen Y, Zhao J, He M, Li X, Zhang L, Dong B, Zhang X, Tang L, Shen L. CT-based delta radiomics in predicting the prognosis of stage IV gastric cancer to immune checkpoint inhibitors. Front Oncol 2022;12:1059874. [PMID: 36686828 DOI: 10.3389/fonc.2022.1059874] [Reference Citation Analysis]
5 Deng Y, Zhao L, Huang X, Zeng Y, Xiong Z, Zuo M. Contribution of skeletal muscle to cancer immunotherapy: A focus on muscle function, inflammation, and microbiota. Nutrition 2023;105:111829. [PMID: 36265324 DOI: 10.1016/j.nut.2022.111829] [Reference Citation Analysis]
6 Wang J, Dong P, Qu Y, Xu W, Zhou Z, Ning K, Peng Y, Xiong L, Li Z, Zou X, Liu Z, Li M, He Z, Luo J, Tian X, Zhang H, Guo S, Han H, Zhou F, Yin S, Ye D, Yu C, Zhang Z. Association of computed tomography-based body composition with survival in metastatic renal cancer patient received immunotherapy: a multicenter, retrospective study. Eur Radiol 2022. [DOI: 10.1007/s00330-022-09345-7] [Reference Citation Analysis]
7 Liu P, Chen S, Gao X, Liang H, Sun D, Shi B, Zhang Q, Guo H. Preoperative sarcopenia and systemic immune-inflammation index can predict response to intravesical Bacillus Calmette-Guerin instillation in patients with non-muscle invasive bladder cancer. Front Immunol 2022;13:1032907. [DOI: 10.3389/fimmu.2022.1032907] [Reference Citation Analysis]
8 Omland LH, Ammitzbøll G, Lund CM, Lindberg H, Dalton SO, Suetta C, Pappot H. Muscle mass and physical function in patients with bladder cancer-Data from a prematurely terminated prospective cohort study. Front Rehabil Sci 2022;3:942475. [PMID: 36275921 DOI: 10.3389/fresc.2022.942475] [Reference Citation Analysis]
9 Ter Maat LS, van Duin IAJ, Elias SG, van Diest PJ, Pluim JPW, Verhoeff JJC, de Jong PA, Leiner T, Veta M, Suijkerbuijk KPM. Imaging to predict checkpoint inhibitor outcomes in cancer. A systematic review. Eur J Cancer 2022;175:60-76. [PMID: 36096039 DOI: 10.1016/j.ejca.2022.07.034] [Reference Citation Analysis]
10 Kankkunen E, Penttilä P, Peltola K, Bono P. C-reactive protein and immune-related adverse events as prognostic biomarkers in immune checkpoint inhibitor treated metastatic renal cell carcinoma patients. Acta Oncol 2022;:1-8. [PMID: 35905053 DOI: 10.1080/0284186X.2022.2104132] [Reference Citation Analysis]